Wednesday’s Radar Play – AMAG

78

AMAG PHARMACEUTICALS INC (NASDAQ:AMAG) received an oft-delayed marketing approval for its Feraheme anemia treatment, clearing the way for the biopharmaceutical company to get the product on shelves in the U.S. during the second half of July.

Market Club has a very interesting take on how AMAG is playing out after the past news report. The “Trade Triangles” paint the picture. CLICK HERE and just enter the ticker (AMAG) your name and e-mail address for the FREE No strings Attached Report sent realtime to your in-box!

Smart Scan Chart Analysis continues positive longer term. Look for this market to remain firm. A triangle indicates the presence of a very strong trend that is being driven by strong forces and AMAG insiders.

FREE Trend Analysis for AMAG Heremagnifyingglass

Comment on this post below.